Last update :
27/11/2025
Anticancer drug   Elranatamab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Elranatamab France
Stability in solutions   injection   Stability in solutions : Elranatamab     
Container Solvent Concentration Temperature Storage Duration of stability References
partially used vials None 40 mg/ml 2-8°C Not specified
9 Day
4942
Manufacturer's stability data

partially used vials None 40 mg/ml 8-30°C Not specified
24 Hour
4942
Manufacturer's stability data

Polypropylen Syringe None 40 mg/ml 2-30°C Not specified
24 Hour
4942
Manufacturer's stability data


  Mentions Légales